ACE activity is modulated by kinin B2 receptor.

Area of Science:

• Biochemistry
• Molecular Biology
• Cardiovascular Physiology

Background:

• Angiotensin-converting enzyme (ACE) regulates key physiological compounds like angiotensin I and bradykinin.
• Recent research suggests ACE/kinin B(2) receptor heterodimerization influences receptor pharmacology.
• The impact of this interaction on ACE enzymatic activity remains largely unexplored.

Purpose of the Study:

• To investigate whether ACE/kinin B(2) receptor interaction affects ACE enzymatic activity.
• To elucidate novel regulatory mechanisms of ACE function.
• To explore the implications for ACE inhibitor-based therapies.

Main Methods:

• ACE catalytic activity was measured using a fluorescence resonance energy transfer (FRET) peptide substrate.
• Experiments were conducted in Chinese hamster ovary (CHO) cells coexpressing ACE and the kinin B(2) receptor.
• The study also utilized endothelial cells from wild-type and kinin B(2) receptor-ablated mice.

Main Results:

• Coexpression of the kinin B(2) receptor significantly augmented ACE activity in CHO cells.
• The ACE activity augmentation was reversed by the B(2) receptor antagonist icatibant.
• Endothelial cells lacking the kinin B(2) receptor exhibited reduced ACE activity compared to wild-type cells.

Conclusions:

• This study provides the first evidence that ACE/kinin B(2) receptor interaction modulates ACE enzymatic activity.
• The findings reveal a novel regulatory pathway influencing ACE function.
• These results may offer new insights into the mechanisms underlying ACE inhibitor therapies and kinin receptor interactions.